Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

Leukemia. 2011 Jan;25(1):181-4. doi: 10.1038/leu.2010.239. Epub 2010 Oct 14.

Authors

R Handgretinger, G Zugmaier, G Henze, H Kreyenberg, P Lang, A von Stackelberg

PMID: 20944674
DOI: 10.1038/leu.2010.239

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Antibodies, Bispecific / therapeutic use*
Child
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Lymphocyte Activation*
Male
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
Recurrence
T-Lymphocytes / immunology*
Tissue Donors*

Substances

Antibodies, Bispecific
blinatumomab